Responsible for developing and managing pricing strategies for new and existing pharmaceutical products, including rebates and pricing structures.

Strong knowledge of PMPRB regulations and Canadian pharmaceutical pricing requirements is essential.

Will lead and manage a team of approximately 6–10 professionals.

Must have pharmaceutical/drug industry experience; medical device or other non-pharma experience alone is not sufficient.

Experience managing large, complex organizations and cross-functional business environments is required.

Responsibilities

Lead, develop and cultivate the Strategic Pricing team, empowering a team culture aligned to Client’s values, fostering an environment of innovation, a solutions-oriented approach to problem solving and a strong focus to achieve results

Establish forward-thinking pricing strategies including list and net price approaches for all client brands: Leads the development and local/global approval of gross and net pricing strategies

Develop viable deal structures for payer negotiations and build innovative, fit-for-purpose contracting solutions for public and private payers that improve near and long term brand contribution

Lead early asset input, shaping pricing and commercial potential

Responsible for adherence to global pricing policies and managing processes for exceptions management

Implement processes for the planning and analyses of rebates and chargebacks for all pricing contracts (public, private, hospital/GPO)

Collaborate with business units to create and communicate the pricing requirements for each business segment, develop the financial models, consolidate data to allow for multiple views of the information, and prepare presentations for leadership review

Work with Commercial Financial Planning to understand the financial impact of current gross-to-net reserves, pipeline stocking, existing and future contracting on Net Sales results





Responsible for pricing compliance and reporting requirements locally and globally including PMPRB reporting, monitoring, and issues management.

Advise and leads client position and response to policy changes that involve pricing aligned to our corporate strategic direction (i.e. PMPRB)

Advise business on net price impact and performance for Patient Support Program offerings including Free Drug Programs and co-pay support – responsible for local and global pricing approvals process related to the above

Establish & monitor pricing metrics including year-over-year price variance by brand and by region, assess net price performance vs. targeted goals

Remain current on pricing environment and engages with industry associations and key industry colleagues to proactively identify emerging trends, opportunities or challenges in the market place including government health policy changes and cost containment initiatives.

Qualifications

Bachelors’ degree in a relevant quantitative specialty. MBA is an asset.

Significant relevant pharmaceutical experience (7-10+ years) in Market Access, including specific dedicated experience in Market Access Strategy or Pricing

Solid understanding and experience with Canadian payer environment and PMPRB specifically

Experienced team and people leader with previous people management experience

Ability to think strategically about complex and systematic challenges, and able to build results oriented approaches

Track record of leveraging analytic rigour to deliver business-optimized solutions

Business knowledge and credibility at senior commercial levels

Strong interpersonal and influencing abilities

Excellent communications skills (written, spoken and presentation)

Strong people leadership skills, passionate about developing teams

Strong negotiation and facilitation skills; strong communication skills

Strategically agile with solid business insight and can synthesize information from diverse sources to build strategies and solutions

📌 RCI-Director Strategic Pricing (Winnipeg)
🏢 Rangam
📍 Winnipeg